Skip to main content
SpringerLink
Log in

Staging and Imaging of Sarcoma

  • Chapter
  • First Online:
Sarcomas of Bone and Soft Tissues in Children and Adolescents

Part of the book series: Pediatric Oncology ((PEDIATRICO))

  • 672 Accesses

Abstract

Staging of soft tissue sarcoma, Ewing sarcoma, and osteosarcoma involves MRI of the primary tumor, computed tomography of the chest, and, in the case of Ewing Sarcoma and rhabdomyosarcoma, evaluation of the bone marrow. FDG PET imaging, when available, is replacing technetium bone scanning for evaluation of metastatic disease in sarcomas and is being investigated to determine response to treatment and prognosis. Staging and risk assignment for rhabdomyosarcoma (RMS) have undergone significant evolution since the original description of the clinical group assignment and modified TNM system. The next generation of RMS studies in the Children’s Oncology Group will use fusion status instead of histologic determination for treatment assignment. For selected low-risk patients, some staging studies can be omitted. There remain some differences in risk and treatment assignment between the European Pediatric Soft Tissue Sarcoma Group and the Children’s Oncology Group.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Arndt CA, Stoner JA, Hawkins DS et al (2009) Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: Children’s Oncology Group Study D9803. J Clin Oncol 27:5182–5188

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Benz MR, Tchekmedyian N, Eilber FC et al (2009) Utilization of positron emission tomography in the management of patients with sarcoma. Curr Opin Oncol 21:345–351

    Article  PubMed  Google Scholar 

  • Buchbender C, Heusner TA, Lauenstein TC et al (2012) Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphoma. J Nucl Med 53:1244–1252

    Article  PubMed  Google Scholar 

  • Burke M, Anderson JR, Kao SC et al (2007) Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience—a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. J Clin Oncol 25:4909–4913

    Article  PubMed  Google Scholar 

  • Casey DL, Wexler LH, Fox JJ et al (2014) Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys 90:1136–1142

    Article  PubMed  Google Scholar 

  • Chakiba C, Lagarde P, Pissaloux D et al (2014) Response to chemotherapy is not related to chromosome instability in synovial sarcoma. Ann Oncol 25:2267–2271

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cheon GJ, Kim MS, Lee JA et al (2009) Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI. J Nucl Med 50:1435–1440

    Article  CAS  PubMed  Google Scholar 

  • Chibon F, Lagarde P, Salas S et al (2010) Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med 16:781–787

    Article  CAS  PubMed  Google Scholar 

  • Crist WM, Anderson JR, Meza JL et al (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19:3091–3102

    Article  CAS  PubMed  Google Scholar 

  • De Corti F, Dall’Igna P, Bisogno G et al (2009) Sentinel node biopsy in pediatric soft tissue sarcomas of extremities. Pediatr Blood Cancer 52:51–54

    Article  PubMed  Google Scholar 

  • Denecke T, Hundsdorfer P, Misch D et al (2010) Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters. Eur J Nucl Med Mol Imaging 37:1842–1853

    Article  PubMed  Google Scholar 

  • Dharmarajan KV, Wexler LH, Gavane S et al (2012) Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 84:996–1002

    Article  PubMed  Google Scholar 

  • Eugene T, Corradini N, Carlier T et al (2012) (1)(8)F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas. Nucl Med Commun 33:1089–1095

    Article  CAS  PubMed  Google Scholar 

  • Federico SM, Spunt SL, Krasin MJ et al (2013) Comparison of PET-CT and conventional imaging in staging pediatric rhabdomyosarcoma. Pediatr Blood Cancer 60:1128–1134

    Article  PubMed  Google Scholar 

  • Ferrari A, Casanova M (2005) Current chemotherapeutic strategies for rhabdomyosarcoma. Expert Rev Anticancer Ther 5:283–294

    Article  CAS  PubMed  Google Scholar 

  • Ferrari A, Bisogno G, Casanova M et al (2002) Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group. J Clin Oncol 20:449–455

    Article  CAS  PubMed  Google Scholar 

  • Ferrari A, Miceli R, Casanova M et al (2007) Adult-type soft tissue sarcomas in paediatric age: a nomogram-based prognostic comparison with adult sarcoma. Eur J Cancer 43:2691–2697

    Article  PubMed  Google Scholar 

  • Ferrari A, Bisogno G, Alaggio R et al (2008) Synovial sarcoma of children and adolescents: the prognostic role of axial sites. Eur J Cancer 44:1202–1209

    Article  PubMed  Google Scholar 

  • Ferrari A, Miceli R, Meazza C et al (2009) Soft tissue sarcomas of childhood and adolescence: the prognostic role of tumor size in relation to patient body size. J Clin Oncol 27:371–376

    Article  PubMed  Google Scholar 

  • Ferrari A, Miceli R, Meazza C et al (2010) Comparison of the prognostic value of assessing tumor diameter versus tumor volume at diagnosis or in response to initial chemotherapy in rhabdomyosarcoma. J Clin Oncol 28:1322–1328

    Article  PubMed  Google Scholar 

  • Ferrari A, De Salvo GL, Oberlin O et al (2012) Synovial sarcoma in children and adolescents: a critical reappraisal of staging investigations in relation to the rate of metastatic involvement at diagnosis. Eur J Cancer 48:1370–1375

    Article  PubMed  Google Scholar 

  • Gerth HU, Juergens KU, Dirksen U et al (2007) Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors. J Nucl Med 48:1932–1939

    Article  PubMed  Google Scholar 

  • Hawkins DS, Schuetze SM, Butrynski JE et al (2005) [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 23:8828–8834

    Article  PubMed  Google Scholar 

  • Hawkins DS, Conrad EU 3rd, Butrynski JE et al (2009) [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer 115:3519–3525

    Article  PubMed  Google Scholar 

  • Hingorani P, Missiaglia E, Shipley J et al (2015) Clinical application of prognostic gene expression signature in fusion gene-negative rhabdomyosarcoma: a report from the Children’s Oncology Group. Clin Cancer Res 21:4733–4739

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Joshi D, Anderson JR, Paidas C et al (2004) Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Pediatr Blood Cancer 42:64–73

    Article  CAS  PubMed  Google Scholar 

  • Klem ML, Grewal RK, Wexler LH et al (2007) PET for staging in rhabdomyosarcoma: an evaluation of PET as an adjunct to current staging tools. J Pediatr Hematol Oncol 29:9–14

    Article  PubMed  Google Scholar 

  • Koscielniak E, Harms D, Henze G et al (1999) Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 17:3706–3719

    Article  CAS  PubMed  Google Scholar 

  • Lawrence W Jr, Anderson JR, Gehan EA et al (1997) Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children’s Cancer Study Group. Pediatric Oncology Group. Cancer 80:1165–1170

    Article  PubMed  Google Scholar 

  • Missiaglia E, Williamson D, Chisholm J et al (2012) PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J Clin Oncol 30:1670–1677

    Article  PubMed  Google Scholar 

  • Mody RJ, Bui C, Hutchinson RJ et al (2010) FDG PET imaging of childhood sarcomas. Pediatr Blood Cancer 54:222–227

    PubMed  PubMed Central  Google Scholar 

  • Oberlin O, Rey A, Sanchez de Toledo J et al (2012) Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study. J Clin Oncol 30:2457–2465

    Article  CAS  PubMed  Google Scholar 

  • Pappo AS, Rao BN, Jenkins JJ et al (1999) Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: the St. Jude Children’s Research Hospital experience. Med Pediatr Oncol 33:76–82

    Article  CAS  PubMed  Google Scholar 

  • Ricard F, Cimarelli S, Deshayes E et al (2011) Additional benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma. Clin Nucl Med 36:672–677

    Article  PubMed  Google Scholar 

  • Rodary C, Flamant F, Donaldson SS (1989) An attempt to use a common staging system in rhabdomyosarcoma: a report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP). Med Pediatr Oncol 17:210–215

    Article  CAS  PubMed  Google Scholar 

  • Rodeberg DA, Garcia-Henriquez N, Lyden ER et al (2011) Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children’s Oncology Group. J Clin Oncol 29:1304–1311

    Article  PubMed  PubMed Central  Google Scholar 

  • Rosenberg AR, Anderson JR, Lyden E et al (2014) Early response as assessed by anatomic imaging does not predict failure-free survival among patients with group III rhabdomyosarcoma: a report from the Children’s Oncology Group. Eur J Cancer 50:816–823

    Article  PubMed  Google Scholar 

  • Skapek SX, Anderson J, Barr FG et al (2013) PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a Children’s Oncology Group report. Pediatr Blood Cancer 60:1411–1417

    Article  PubMed  PubMed Central  Google Scholar 

  • Spunt SL, Poquette CA, Hurt YS et al (1999) Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children’s Research Hospital. J Clin Oncol 17:3697–3705

    Article  CAS  PubMed  Google Scholar 

  • Spunt SL, Hill DA, Motosue AM et al (2002) Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Clin Oncol 20:3225–3235

    Article  PubMed  Google Scholar 

  • Spunt SL, Million L, Chi Y et al (2020) A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a children’s oncology group prospective study. Lancet Oncol. 21(1):145–161

    Google Scholar 

  • Stewart RJ, Martelli H, Oberlin O et al (2003) Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the malignant mesenchymal tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology. J Clin Oncol 21:793–798

    Article  PubMed  Google Scholar 

  • Sultan I, Ferrari A (2010) Selecting multimodal therapy for rhabdomyosarcoma. Expert Rev Anticancer Ther 10:1285–1301

    Article  PubMed  Google Scholar 

  • Tateishi U, Kawai A, Chuman H et al (2011) PET/CT allows stratification of responders to neoadjuvant chemotherapy for high-grade sarcoma: a prospective study. Clin Nucl Med 36:526–532

    Article  PubMed  Google Scholar 

  • Volker T, Denecke T, Steffen I et al (2007) Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 25:5435–5441

    Article  PubMed  Google Scholar 

  • Wegner EA, Barrington SF, Kingston JE et al (2005) The impact of PET scanning on management of paediatric oncology patients. Eur J Nucl Med Mol Imaging 32:23–30

    Article  CAS  PubMed  Google Scholar 

  • Weigel BJ, Lyden E, Anderson JR et al (2016) Intensive multiagent therapy, including dose-compressed cycles of Ifosfamide/etoposide and vincristine/doxorubicin/cyclophosphamide, irinotecan, and radiation, in patients with high-risk rhabdomyosarcoma: a report from the Children’s Oncology Group. J Clin Oncol 34:117–122

    Article  CAS  PubMed  Google Scholar 

  • Weiss BD, Dasgupta R, Gelfand MJ et al (2011) Use of sentinel node biopsy for staging parameningeal rhabdomyosarcoma. Pediatr Blood Cancer 57:520–523

    Article  PubMed  Google Scholar 

  • Weiss AR, Lyden ER, Anderson JR et al (2013) Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. J Clin Oncol 31:3226–3232

    Article  PubMed  PubMed Central  Google Scholar 

  • Williamson D, Missiaglia E, de Reynies A et al (2010) Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 28:2151–2158

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mayo Clinic, Rochester, MN, USA

    Carola A. S. Arndt

  2. Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

    Andrea Ferrari

Authors
  1. Carola A. S. Arndt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carola A. S. Arndt .

Editor information

Editors and Affiliations

  1. Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA

    Carola A. S. Arndt

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Arndt, C.A.S., Ferrari, A. (2021). Staging and Imaging of Sarcoma. In: Arndt, C.A.S. (eds) Sarcomas of Bone and Soft Tissues in Children and Adolescents. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-51160-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-51160-9_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-51158-6

  • Online ISBN: 978-3-030-51160-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation